Ratings by Wells Fargo (Sadia Rahman)

More Stocks Rated by Wells Fargo
Date CompanySymbol Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/4/2025 Maze Therapeutics MAZE New Coverage Overweight
(N/A)		 37.27
(44.83)		 20.28% Details